Search Awardees

Angiotech Pharmaceuticals

UEI: JKYZFZSJPQJ7

Overview

Awardee Type
Parent (1 child)
Company Description
Corza Medical is a leading global manufacturer of innovative surgical technologies. With a global team of over 1,800 employees supporting clinicians, distributors and medical device companies worldwide, Corza provides healthcare professionals a platform of surgical technologies with industry-leading brands.
Name
Angiotech Pharmaceuticals
Headquarters
Westwood, MA
United States
Federal contract recipient SURGICAL SPECIALTIES CORPORATION (UEI JKYZFZSJPQJ7) is headquartered in Westwood MA. Its primary registered NAICS is 339112 Surgical and Medical Instrument Manufacturing. The corporation was founded in February 1997 and federally registered in July 2001.

Federal Award Analysis

Angiotech Pharmaceuticals federal award history

$-

Contracts

$-

Subcontracts

$-

Grants

$-

Subgrants

$-

Total

Interactive Stacked Bar Chart


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating
Year Contracts Subcontracts Grants Subgrants


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating


No Results
Calculating
Calculating

Federal Registration and Certifications

Legal Name
SURGICAL SPECIALTIES CORPORATION
UEI
KF1NG11LNK49
CAGE Code
1BQQ6
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)

People

Vendor contacts at Angiotech Pharmaceuticals

Subscribe to find 500K+ key government decision markers

Free Trial Schedule Demo

Contract Vehicles

Angiotech Pharmaceuticals multi-award contract vehicles

IDV Awards

Angiotech Pharmaceuticals indefinite delivery vehicle awards

Contract Awards

Angiotech Pharmaceuticals prime contract awards

Subcontract Awards

Angiotech Pharmaceuticals subcontract awards

Approved Supplier

CAGE 1BQQ6 Defense Logistics Agency approved NSNs

Teaming Partners

Disclosed awardee sub and prime contract and grant relationships

Angiotech Pharmaceuticals